Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pfizer Selects Preclinical Candidate from TCGLS | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Pfizer Selects Preclinical Candidate from TCGLS

Indian partner will receive future success-based milestone payment

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer has selected a preclinical development candidate under its R&D collaboration with TCG Lifesciences Ltd. (TCGLS). Pfizer will own the candidate and other backup candidates and TCGLS will receive a success-based milestone payment.
 
The candidate is a small molecule new chemical entity that has met Pfizer’s criteria, including potency, pharmacokinetics, animal pharmacology, toxicology and related parameters.

Mr. Swapan Bhattacharya, managing director, TCGLS, said, “We have established an excellent track record in our long term collaboration with Pfizer and this candidate nomination is a key milestone of the success of this partnership. This success also demonstrates the progress made by TCGLS in supporting innovation. I sincerely acknowledge the dedication of both the Pfizer and TCGLS scientific teams and congratulate them for this achievement.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics